Abstract
Background
The presence of infarction in patients with unrecognized myocardial infarction (UMI) is a critical feature in predicting adverse cardiac events. This study aimed to compare the detection rate of UMI using conventional and deep learning reconstruction (DLR)-based late gadolinium enhancement (LGEO and LGEDL, respectively) and evaluate optimal quantification parameters to enhance diagnosis and management of suspected patients with UMI.
Methods
This prospective study included 98 patients (68 men; mean age: 55.8 ± 8.1 years) with suspected UMI treated at our hospital from April 2022 to August 2023. LGEO and LGEDL images were obtained using conventional and commercially available inline DLR algorithms. The myocardial signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and percentage of enhanced area (Parea) employing the signal threshold versus reference mean (STRM) approach, which correlates the signal intensity (SI) within areas of interest with the average SI of normal regions, were analyzed. Analysis was performed using the standard deviation (SD) threshold approach (2SD–5SD) and full width at half maximum (FWHM) method. The diagnostic efficacies based on LGEDL and LGEO images were calculated.
Results
The SNRDL and CNRDL were two times better than the SNRO and CNRO, respectively (P < 0.05). Parea−DL was elevated compared to Parea−O using the threshold methods (P < 0.05); however, no intergroup difference was found based on the FWHM method (P > 0.05). The Parea−DL and Parea−O also differed except between the 2SD and 3SD and the 4SD/5SD and FWHM methods (P < 0.05). The receiver operating characteristic curve analysis revealed that each SD method exhibited good diagnostic efficacy for detecting UMI, with the Parea−DL having the best diagnostic efficacy based on the 5SD method (P < 0.05). Overall, the LGEDL images had better image quality. Strong diagnostic efficacy for UMI identification was achieved when the STRM was ≥ 4SD and ≥ 3SD for the LGEDL and LGEO, respectively.
Conclusions
STRM selection for LGEDL magnetic resonance images helps improve clinical decision-making in patients with UMI. This study underscored the importance of STRM selection for analyzing LGEDL images to enhance diagnostic accuracy and clinical decision-making for patients with UMI, further providing better cardiovascular care.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12880-024-01308-2.
Keywords: Deep learning reconstruction, Diagnostic efficacy, Late gadolinium enhancement, Magnetic resonance imaging, Unrecognized myocardial infarction
Background
Myocardial infarction (MI) is diagnosed based on the detection of acute myocardial injury according to cardiac biomarker abnormalities in the context of acute myocardial ischemia [1]. Unrecognized MI (UMI) is a type of MI that has yet to be clinically diagnosed, with the prevalence increasing by 10.0% every decade [2]. Delayed detection due to atypical symptoms can delay treatment, leading to poor prognosis [3]. Failure to achieve reperfusion within a few hours after blood flow cessation may cause myocardial apoptosis in vessel-supplied regions. Therefore, determining the presence or absence of MI and quantifying related variables are crucial in improving the diagnosis, treatment, and prognosis [4, 5].
Cardiac magnetic resonance (CMR) imaging is a promising tool for MI detection because of good tissue contrast and spatial resolution. However, patient compliance is challenging for several reasons, such as the requirement to acquire each high-resolution slice and the need for stable respiration; furthermore, certain conditions, including unstable heartbeat and arrhythmia, can cause motion artifacts on free-breathing scans. As relatively shorter breath-holds are required to acquire more slices, higher-spatial resolution late gadolinium enhancement (LGE) is most frequently utilized in magnetic resonance imaging (MRI) to observe and quantify the degree of myocardial necrosis and microvascular occlusion. Although the enhancement is achieved semi-automatically using post-processing software, the initial sketch of the endocardium, epicardium, enhanced myocardium, and remote normal myocardium relies on the reader’s experience to some extent [6]. Additionally, a previous study reported that LGE could identify only 23 of the 872 participants (2.6%) with UMI [7]. The clinical significance of UMI has been reported using different imaging techniques in diagnosing, refining risk stratification, and guiding clinical decisions for treatments. All underscored the role of CMR in improving the detection accuracy of UMIs, which may affect adverse cardiac outcomes and optimize cardiovascular disease management [8–10]. Therefore, timely and accurate UMI identification and assessment are fundamental for patient stratification and therapeutic planning [4, 5, 11]. In practice, despite many applications of standard deviation (SD) and full width at half maximum (FWHM) techniques, no consensus exists for quantifying scars on LGE images; this challenge persists across different cardiac diseases [12–14]. Obviously, a gap exists in current diagnostic frameworks for analyzing myocardium delayed enhancement.
Deep learning (DL) methods can improve image quality and eliminate intra- and inter-observer variability, enabling more accurate diagnosis and treatment strategies [15, 16] and segmentation for precisely sketched lesions [17–21], among others. However, no DL reconstruction (DLR)-based magnetic resonance (MR) studies have evaluated patients with suspected UMI. Therefore, this study aimed to explore the feasibility and diagnostic performance of DLR-based LGE imaging (LGEDL) for patients with UMI compared with that of conventional imaging (LGEO) and propose an appropriate signal threshold versus reference mean (STRM) for analyzing LGEDL.
Methods
Study population
This study prospectively recruited 98 patients (68 men and 30 women, mean age: 55.8 ± 8.1 years) who presented at our hospital between April 2022 and August 2023 without typical MI symptoms, such as angina pectoris of cardiogenic origin but with suspected UMI after a physical examination. Based on the guidelines of European and American associations and previous reports [1, 7, 22], the inclusion criteria were as follows: (i) the absence of typical angina symptoms; (ii) the presence of elevated or decreased serum cardiac troponin (cTn) levels, with at least one instance of elevation above the upper limit of the normal value (the 99th percentile of the reference value’s upper limit); (iii) prior evidence of MI on electrocardiography in the absence of left ventricular hypertrophy and left bundle branch block; and (iv) no prior history of oncological disease or surgery for cardiovascular diseases. The exclusion criteria were as follows: (i) clinically unstable condition, decompensated heart failure, contraindication to CMR, an estimated glomerular filtration rate ≤ 30 mL/min, and contraindication to the use of gadolinium contrast; and (ii) LGE images that could not be used for clinical diagnosis and objective assessments (Fig. 1).
Fig. 1.
Flowchart of patient enrolment and exclusion. Note: cTn: cardiac troponin; ECG: electrocardiogram; LGEO: conventionally constructed late gadolinium enhancement; LGEDL: deep learning-based reconstruction late gadolinium enhancement; UMI: unrecognized myocardial infarction; SD: standard deviation; SNR: signal-to-noise ratio; CNR: contrast-to-noise ratio
CMR examination and image construction
All patients underwent a routine cardiac MRI examination, including a short-axis LGE imaging sequence, on a 3.0-T MRI scanner (Signa Architect, GE Healthcare, Waukesha, WI, USA) at our hospital. A new commercial inline deep-learning-based reconstruction (DLR, brand name: AIR™ Recon DL, DV29.1_R04, GE Healthcare, USA) employs no bias terms and rectified linear unit activations to identify 4.4 million features on directly received image data immediately after scanning on an MR console computer to reduce noise and Gibbs artifacts, and further eliminate intra- and inter-observer differences [13, 16]. The parameters for the LGE sequence were as follows: echo time = 2.7 ms; repetition time = 5.6 ms; flip angle = 25°; field of view = 34 cm × 34 cm; matrix = 260 × 174; slice thickness = 8 mm; slice spacing = 2 mm; receiver bandwidth = 83.33 kHz; views per segment = 24; number of excitations = 1; and theoretical acquisition time = 8 s×nine heart beats. The LGEO and LGEDL were simultaneously generated using conventional inline reconstruction and AIR™ Recon DL algorithms. Fifteen minutes before LGE sequence scanning, a single bolus of 0.1 mmol/kg (0.2 ml/kg) Gadobenate Dimeglumine (Bracco Imaging S.P.A., Milano, Italy) was administered, followed by 20-mL saline flush at a flow rate of 2 ml/s [23]. This dosage was selected based on its efficacy of myocardial enhancement for visualization under the condition of patient safety.
Assessment of myocardial enhancement area and diagnostic efficacy
Ultimately, data from 61 patients with myocardial enhancement were included in the analysis (43 men [70.5%] and 18 women [29.5%]), with a mean age of 55.9 ± 8.7 years (Fig. 1). The percentage of whole-heart myocardial enhancement area (Parea) in segments S1–S16 was assessed semi-quantitatively to diagnose cardiovascular disease using Circle Cardiovascular Imaging Inc. (cvi42, Circle Cardiovascular Imaging Inc., Calgary, AB, Canada). The delayed enhancement area (i.e., scar size) was subsequently quantified based on threshold methods, which involve adding 2–5 times SD to the mean signal intensity (SI) of the reference myocardium, and the FWHM method, which identifies the half maximum SI at the full width of SI distribution within one region of interest (ROI) in the myocardial tissue. The Parea was calculated as the scar size divided by the myocardial volume. Furthermore, the diagnostic efficacy of the Parea of LGEDL and LGEO images (Parea−DL and Parea−O, respectively) in differentiating patients with UMI was assessed, with the clinical diagnosis of UMI as the gold standard.
Theory/calculation
CMR image assessment
Qualitative and quantitative imaging evaluations were performed double-blindedly by two radiologists with > 5 years of experience in CMR diagnosis. Moreover, one of the radiologists repeated the assessment 1 month later.
Image quality
For the objective evaluation of image quality, ROIs were on LGEO and LGEDL images to determine the SI of the normal myocardium (SIMyo−O and SIMyo−DL, respectively) and myocardial delayed enhancement area (SIMDEA−O and SIMDEA−DL, respectively), as well as the SD of the background noise at the corner of the images (SDBG−O and SDBG−DL, respectively) and the myocardial delayed enhancement area (SDMDEA−O and SDMDEA−DL, respectively) (Fig. 2). Additionally, for LGEO and LGEDL images, the myocardial signal-to-noise ratios (SNRs) (SNRO and SNRDL, respectively) and contrast-to-noise ratios (CNRs) (CNRO and CNRDL, respectively) were calculated [9, 10, 24, 25] using the following formulae:
Fig. 2.
Schematic diagram of Parea using accordingly (a.II) and (b.III) 4SD, (b.II) 3SD, (a.III) 5SD, (a.IV) and (b.IV) FWHM methods for (a) LGEDL images, (b) LGEO images, and (a. V) electrocardiogram of a patient with UMI. Figure 2(a) shows clearer, less noisy, more uniform normal myocardial signal and better contrast between the enhancement area and normal myocardium than Fig. 2(b). The patient with UMI underwent stress perfusion myocardium and received an intravenous injection of 20 mCi 99mTc-MIBI. The stress perfusion maps as Fig. 2(b. V) supported our Parea maps with clearer myocardium enhancement in the enlarged left ventricle, with the morphological anomaly, relatively light sparsity of 20 mCi 99mTc-MIBI (a radiation tracker, RT) in the middle and basal segments of the anterior wall and the middle segment of the anteroseptal wall, relatively strong sparsity of RTs in the apex, the apical segment of the septal wall, the middle and basal segments of the posteroseptal wall, the apical, middle, and basal segments of the inferior wall, the apical segment of the lateral wall, and the middle and basal segments of posterolateral, and normal perfusion in the remaining myocardium. Note: SD: standard deviation; 2, 3, 4, and 5SD threshold methods: mean Parea respectively adding 2, 3, 4, and 5 times of standard deviation of Parea as the threshold for myocardial enhancement area; FWHM: full width at half maximum; LGEDL: deep learning-based reconstruction late gadolinium enhancement; LGEO: conventionally constructed late gadolinium enhancement; UMI: unrecognized myocardial infarction
![]() |
)
The short-axis LGEO and LGEDL images were divided into 16 segments based on the American Heart Association criteria, and the SNR and CNR of each segment were calculated.
Statistical analysis
All data were statistically analyzed using R-project software (version 4.0.4, http://www.r-project.org). Quantitative data are expressed as either the‾x ± SD or median (interquartile range). All quantitative data were analyzed using either a paired t-test or a Wilcoxon signed-rank test depending on the results of the Shapiro–Wilk and Levene’s tests, which were used to assess variance homogeneity and data normality, respectively. To control the false discovery rate, we applied the Benjamini–-Hochberg method for multiple comparison corrections. The intraclass correlation coefficients (ICCs) of the objective quantitative indicators, including the SNR, CNR, SD, and Parea for LGEO and LGEDL images (SNRO, SNRDL, CNRO, CNRDL, SDO, SDDL, Parea−O and Parea−DL, respectively) were quantified to assess the degree of intra- and inter-observer agreement. Receiver operating characteristic (ROC) curves for Parea−DL and Parea−O were constructed using the different threshold methods to determine and compare their diagnostic efficacies for the UMI or non-UMI groups based on the area under the curve (AUC). All statistical significance was set at P < 0.05.
Results
Patient characteristics
Overall, 77 patients (53 men and 24 women; mean age: 55.6 ± 8.4 years) were diagnosed with UMI based on various clinical indicators, including the cTn level (n = 77), imaging features on electrocardiography (n = 77), ultrasound cardiography (n = 18), computed tomography angiography (n = 14), and digital subtraction angiography (n = 38), or nuclear medicine test results (n = 8). Sixty-one patients (43 men and 18 women; mean age: 55.9 ± 8.7 years) who met the UMI diagnostic criteria were evaluated to assess the distribution of the supplying vessels and the presence of infarction in LGE images. The non-UMI group predominantly exhibited hypertrophic cardiomyopathy (n = 10, 71.43%) and left bundle branch block (n = 4, 28.57%) (Fig. 1).
Objective evaluation of image quality
The SDs of the normal myocardium, delayed myocardial enhancement areas, and background of the images are presented in Table 1. The SDDL values were lower than the SDO values in all 16 segments, with the S1 segment exhibiting the most significant difference between SDDL and SDO images (31.95 ± 21.82 vs. 45.74 ± 28.29, P < 0.05). Overall, the SDMyo−DL, SDMDEA−DL, and SDBG−DL values of LGEDL images were lower than the respective values of LGEO images, including the SDMyo−O (36.38 ± 19.55 vs. 46.03 ± 18.65, P < 0.05), SDMDEA−O (47.39 ± 41.22 vs. 59.77 ± 44.08, P < 0.05), and SDBG−O (3.14 ± 2.48 vs. 6.17 ± 4.03, P < 0.05). The SNRDL values were higher than the SNRO values in all 16 segments (P < 0.001), with the most significant difference observed in the S16 segment (92.44 ± 78.39 vs. 27.39 ± 24.56, respectively; P < 0.05). The S1 segment exhibited the highest SNRDL (113.89 ± 98.62), and the S2 segment had the highest SNRO (39.10 ± 41.45). The whole myocardial SNRDL and whole delayed myocardial enhancement CNRDL were significantly elevated compared to the whole myocardial SNRO (99.93 ± 81.42 vs. 33.29 ± 30.89, P < 0.05) and whole delayed enhanced myocardium CNRO (123.72 ± 45.00 vs. 60.15 ± 15.52, P < 0.05), respectively (Fig. 2a-b–.I, Supplementary Fig. 1a–d.I). The SIDL values were higher than the respective SIO values for all segments (P < 0.05) except for S7–S9 and S11. In comparing the SIMyo−DL and SIMyo−O values, the SIDL values were higher than the corresponding SIO values for S1–S6, S10, and S12–S16 (P < 0.05). The SIDL values were slightly higher than the corresponding SIO values for S7–S9 or S11; however, the difference was not significant (P > 0.05) (Fig. 3a).
Table 1.
Objective evaluation of image quality for LGEDL and LGEO
| SD | SNR | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| LGE DL | LGE O | t/Z | p | LGE DL | LGE O | t/Z | p | ||
| S1 | 31.95 ± 21.82 | 45.74 ± 28.29 | 5.592 | < 0.05 | 113.89 ± 98.62 | 33.58 ± 33.36 | 4.759 | < 0.05 | |
| S2 | 36.04 ± 28.27 | 47.19 ± 30.01 | 4.522 | < 0.05 | 106.97 ± 103.87 | 39.10 ± 41.45 | 3.724 | < 0.05 | |
| S3 | 43.34 ± 30.63 | 52.37 ± 26.63 | 3.272 | < 0.05 | 98.82 ± 93.38 | 38.16 ± 41.42 | 3.667 | < 0.05 | |
| S4 | 33.05 ± 20.62 | 49.28 ± 23.02 | 5.498 | < 0.05 | 91.24 ± 85.00 | 32.62 ± 34.86 | 4.033 | < 0.05 | |
| S5 | 39.44 ± 21.07 | 54.61 ± 24.43 | 5.111 | < 0.05 | 103.87 ± 98.09 | 38.78 ± 39.78 | 3.767 | < 0.05 | |
| S6 | 32.77 ± 16.73 | 45.97 ± 23.14 | 5.014 | < 0.05 | 94.96 ± 85.96 | 33.38 ± 36.85 | 4.105 | < 0.05 | |
| S7 | 34.42 ± 27.18 | 40.79 ± 22.09 | 2.521 | < 0.05 | 100.95 ± 86.57 | 32.86 ± 30.23 | 4.83 | < 0.05 | |
| S8 | 30.44 ± 26.95 | 44.75 ± 39.61 | 4.877 | < 0.05 | 105.97 ± 94.58 | 33.87 ± 33.44 | 4.493 | < 0.05 | |
| S9 | 36.21 ± 29.37 | 45.13 ± 29.37 | 4.374 | < 0.05 | 96.92 ± 86.47 | 34.78 ± 37.62 | 4.155 | < 0.05 | |
| S10 | 37.10 ± 27.54 | 47.98 ± 29.08 | 4.647 | < 0.05 | 104.39 ± 90.32 | 34.46 ± 35.53 | 4.399 | < 0.05 | |
| S11 | 40.92 ± 32.34 | 49.84 ± 32.27 | 3.390 | < 0.05 | 98.00 ± 88.76 | 35.03 ± 34.21 | 4.241 | < 0.05 | |
| S12 | 40.24 ± 22.70 | 45.43 ± 21.20 | 2.704 | < 0.05 | 97.53 ± 85.58 | 30.49 ± 32.78 | 4.845 | < 0.05 | |
| S13 | 28.45 ± 18.92 | 38.97 ± 21.52 | 4.845 | < 0.05 | 102.41 ± 91.98 | 33.74 ± 33.13 | 4.522 | < 0.05 | |
| S14 | 31.75 ± 22.24 | 40.39 ± 24.62 | 5.046 | < 0.05 | 82.85 ± 80.32 | 24.64 ± 27.49 | 4.371 | < 0.05 | |
| S15 | 33.68 ± 21.04 | 43.25 ± 24.02 | 3.081 | < 0.05 | 107.57 ± 95.83 | 29.81 ± 29.20 | 4.866 | < 0.05 | |
| S16 | 36.33 ± 22.36 | 44.71 ± 25.96 | 2.956 | < 0.05 | 92.44 ± 78.39 | 27.39 ± 24.56 | 5.039 | < 0.05 | |
| WM | 36.38 ± 19.55 | 46.03 ± 18.65 | 5.789 | < 0.05 | 99.93 ± 81.42 | 33.29 ± 30.89 | 4.644 | < 0.05 | |
| MDEA | 47.39 ± 41.22 | 59.77 ± 44.08 | 6.206 | < 0.05 | |||||
| BG | 3.14 ± 2.48 | 6.17 ± 4.03 | 6.052 | < 0.05 | |||||
Note: SD, standard deviation; SNR, signal-to-noise ratio; WM, whole myocardium; MDEA, myocardium delayed enhancement area; BG, background
Fig. 3.
(a) Signal intensity of the left ventricular myocardial on LGEDL and LGEO images. Percentage areas of left ventricular myocardial enhancement in LGEDL and LGEO images using (b. I) 2SD, (b. II) 3SD, (b. III) 4SD, (b. IV) 5SD, and (c) FWHM methods for quantification. Note: SI: signal intensity; WM: whole myocardium; Parea: percentage of myocardial enhancement area; LGEDL: deep learning-based reconstruction late gadolinium enhancement; LGEO: conventionally constructed late gadolinium enhancement;; SD: standard deviation; 2, 3, 4, and 5SD threshold methods: mean Parea respectively adding 2, 3, 4, and 5 times of standard deviation of Parea as the threshold for myocardial enhancement area; FWHM: full width at half maximum; DL, deep learning late gadolinium enhancement; O: original late gadolinium enhancement
Parea assessment
The myocardial enhancement area was semi-quantitatively analyzed using various SD thresholds and the FWHM method. For the 2SD (Fig. 3b.I, Supplementary Figs. 1), 3SD (Figs. 2 and 3b.II, Supplementary Fig. 1), and 5D methods (Figs. 2 and 3b.IV, Supplementary Fig. 1), the Parea−DL values for the overall myocardium were higher than the corresponding Parea−O values for all 16 segments. For the 4SD method, the Parea−DL values of the overall myocardium were higher than the corresponding Parea−O values only in S1–S12 (Figs. 2 and 3b.III, Supplementary Fig. 1). For the FWHM method (Figs. 2 and 3.c, Supplementary Fig. 1), the Parea−DL values were slightly higher than the corresponding Parea−O values for all segments.
Regarding the DLR-based Parea, the overall different threshold and FWHM-based Parea−DL values were higher than those based on any other approach (all P < 0.05). Regarding the Parea−O, the values for the 2SD threshold were significantly higher than those based on other approaches (all P < 0.05) (Table 2).
Table 2.
Differences between different-threshold and FWHM methods
| LGEDL | LGEO | ||||||
|---|---|---|---|---|---|---|---|
| t | p | t | p | ||||
| 2SD Parea vs. 3SD Parea | 41.32 ± 12.78 vs. 39.83 ± 16.58 | 1.454 | >0.05 | 32.81 ± 12.59 vs. 31.41 ± 16.07 | 1.808 | >0.05 | |
| 2SD Parea vs. 4SD Parea | 41.32 ± 12.78 vs. 30.57 ± 15.25 | 8.390 | < 0.05 | 32.81 ± 12.59 vs. 23.96 ± 12.79 | 7.644 | < 0.05 | |
| 2SD Parea vs. 5SD Parea | 41.32 ± 12.78 vs. 28.53 ± 12.92 | 12.072 | < 0.05 | 32.81 ± 12.59 vs. 19.98 ± 12.73 | 11.836 | < 0.05 | |
| 2SD Parea vs. FWHM Parea | 41.32 ± 12.78 vs. 17.25 ± 11.22 | 10.567 | < 0.05 | 32.81 ± 12.59 vs. 17.18 ± 11.12 | 7.375 | < 0.05 | |
| 3SD Parea vs. 4SD Parea | 39.83 ± 16.58 vs. 30.57 ± 15.25 | 10.342 | < 0.05 | 31.41 ± 16.07 vs. 23.96 ± 12.79 | 7.468 | < 0.05 | |
| 3SD Parea vs. 5SD Parea | 39.83 ± 16.58 vs. 28.53 ± 12.92 | 10.963 | < 0.05 | 31.41 ± 16.07 vs. 19.98 ± 12.73 | 14.059 | < 0.05 | |
| 3SD Parea vs. FWHM Parea | 39.83 ± 16.58 vs. 17.25 ± 11.22 | 8.878 | < 0.05 | 31.41 ± 16.07 vs. 17.18 ± 11.12 | 5.695 | < 0.05 | |
| 4SD Parea vs. 5SD Parea | 30.57 ± 15.25 vs. 28.53 ± 12.92 | 2.142 | < 0.05 | 23.96 ± 12.79 vs. 19.98 ± 12.73 | 5.474 | < 0.05 | |
| 4SD Parea vs. FWHM Parea | 30.57 ± 15.25 vs. 17.25 ± 11.22 | 5.733 | < 0.05 | 23.96 ± 12.79 vs. 17.18 ± 11.12 | 3.048 | < 0.05 | |
| 5SD Parea vs. FWHM Parea | 28.53 ± 12.92 vs. 17.25 ± 11.22 | 4.964 | < 0.05 | 19.98 ± 12.73 vs. 17.18 ± 11.12 | 1.314 | >0.05 | |
Note: LGEDL, deep learning-based reconstruction late gadolinium enhancement; LGEO, conventionally constructed late gadolinium enhancement; Parea, percentage of myocardial enhancement area; FWHM, full width at half maximum
Assessment of the consistency of the quantitative measurements
The degree of intra- and inter-observer agreement for the objective measurements (SDMyo, SDMDEA, SDBG, SNR, CNR, and SIMyo) and Parea between LGEDL and LGEO images was good based on the various SD and FWHM methods (for objective measurements: all ICCs > 0.60, all P < 0.05; for Parea: all ICCs > 0.70, P < 0.05). These measurements were better for LGEDL images than for LGEO images (Figs. 4 and 5).
Fig. 4.

Bland–Altman plots for the intra-observer (a) SD of myocardium, enhancement area, and background noise; (b) SNR, CNR, SIMyo; (c) 2SD, 3SD, 4SD, 5SD, FWHM; 95% confidence intervals are labelled. There is a very good interstudy agreement for SD and FWHM methods. (1) LGEDL images, (2) LGEO images. Note: DL, deep learning late gadolinium enhancement; O: original late gadolinium enhancement; SDMyo: standard deviation of normal myocardium; SDMDEA: standard deviation of myocardial delayed enhanced area; SDBG: standard deviation of noise at the corner (background) of images; SNR: signal-to-noise ratio; CNR: contrast-to-noise ratio; SIMyo: signal intensity of normal myocardium; Parea: percentage of myocardial enhancement area; 2, 3, 4, and 5SD threshold methods: mean Parea respectively adding 2, 3, 4, and 5 times of standard deviation of Parea as the threshold for myocardial enhancement area; FWHM: full width at half maximum; LGEDL: deep learning-based reconstruction late gadolinium enhancement; LGEO: conventionally constructed late gadolinium enhancement
Fig. 5.

Bland–Altman plots for the inter- observer analysis; (a) SD of myocardium, enhancement area, and background noise; (b) SNR, CNR, SIMyo; (c) 2SD, 3SD, 4SD, 5SD, FWHM; 95% confidence intervals are labelled. There is a very good interstudy agreement for SD and FWHM methods. (1) LGEDL images, (2) LGEO images. Note: DL: deep learning late gadolinium enhancement; O: original late gadolinium enhancement; SDMyo: standard deviation of normal myocardium; SDMDEA: standard deviation of myocardial delayed enhanced area; SDBG: standard deviation of noise at the corner (background) of images; SNR: signal-to-noise ratio; CNR: contrast-to-noise ratio; SIMyo: signal intensity of normal myocardium; Parea: percentage of myocardial enhancement area; 2, 3, 4, and 5SD threshold methods: mean Parea respectively adding 2, 3, 4, and 5 times of standard deviation of Parea as the threshold for myocardial enhancement area; FWHM: full width at half maximum; LGEDL: deep learning-based reconstruction late gadolinium enhancement; LGEO: conventionally constructed late gadolinium enhancement
Analysis and comparison of diagnostic efficacy
All SD methods exhibited good diagnostic efficacy for UMI, with AUC values of the ROC curves ≥ 0.78. The Parea−DL based on the 5SD threshold method exhibited the optimal diagnostic efficacy of 0.891 (sensitivity = 0.688 and specificity = 1). For the conventional imaging enhancement, the Parea−O based on the 3SD method exhibited the optimal diagnostic efficacy of 0.840. The diagnostic efficacy was better for LGEDL images than for LGEO images for UMI detection for every SD threshold method, whereas it was not different between LGEDL and LGEO parameters based on the FWHM method (Table 3; Fig. 6).
Table 3.
Area under the curve (AUC) for differentiation of UMI or non-UMI groups
| P area | Area | Standard error | P | Approaching 95% confidence interval | |
|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||
| 2SD Parea−DL | 0.859 | 0.066 | < 0.05 | 0.730 | 0.988 |
| 2SD Parea−O | 0.824 | 0.073 | < 0.05 | 0.681 | 0.967 |
| 3SD Parea−DL | 0.887 | 0.057 | < 0.05 | 0.775 | 0.998 |
| 3SD Parea−O | 0.840 | 0.069 | < 0.05 | 0.705 | 0.975 |
| 4SD Parea−DL | 0.855 | 0.066 | < 0.05 | 0.725 | 0.986 |
| 4SD Parea−O | 0.781 | 0.084 | < 0.05 | 0.616 | 0.947 |
| 5SD Parea−DL | 0.891 | 0.056 | < 0.05 | 0.781 | 0.999 |
| 5SD Parea−O | 0.781 | 0.085 | < 0.05 | 0.615 | 0.947 |
| FWHM Parea−DL | 0.797 | 0.079 | < 0.05 | 0.642 | 0.951 |
| FWHM Parea−O | 0.797 | 0.079 | < 0.05 | 0.643 | 0.951 |
Note: SD, standard deviation; Parea−DL, percentage of myocardial enhancement area with deep learning late gadolinium enhancement; Parea−O, percentage of myocardial enhancement area with original late gadolinium enhancement; 2, 3, 4, and 5SD threshold methods, mean Parea respectively adding 2, 3, 4, and 5 times of standard deviation of Parea as the threshold for myocardial enhancement area; FWHM, full width at half maximum
Fig. 6.

Diagnostic efficacy for UMI. Note: UMI: unrecognised myocardial infarction; SD: standard deviation; Parea-DL, percentage of myocardial enhancement area with deep learning late gadolinium enhancement; Parea-O, percentage of myocardial enhancement area with original late gadolinium enhancement; 2, 3, 4, and 5SD threshold methods, mean Parea respectively adding 2, 3, 4, and 5 times of standard deviation of Parea as the threshold for myocardial enhancement area; FWHM: full width at half maximum
Discussion
This study compared LGEO and LGEDL images based on different SD thresholds and the FWHM method. The significant differences in Parea values between LGEO and LGEDL images for the SD threshold methods but not for the FWHM method suggested that the STRM should be ≥ 3, regardless of whether conventional or DLR-based LGE images are used, as previously reported. An STRM ≥ 4 and Parea−DL values based on the 5SD threshold exhibited the highest diagnostic efficacy for detecting UMI. Additionally, the LGEDL images generated in this study could display the delayed enhancement area in patients with UMI for the first time, with significantly better image quality than was previously achievable with LGEO images, such as artifacts in the myocardium, intensified foci and lower background noise, lower SD, and higher SNR and CNR values in all patients with UMI. Thus, LGEDL imaging can improve diagnostic confidence without impacting diagnostic efficacy.
The presence of an infarction in patients with UMI is a critical feature for predicting adverse cardiac events [26–28]. The Parea on LGE images is the most frequently used direct indicator of irreversible damage at the pathological tissue level and can predict the treatment response to cardioprotective interventions [29, 30]. However, the clinical approach for quantifying the myocardial enhancement area is not uniform, with SD thresholds used in some instances and the FWHM method employed in others. Additionally, the generation of LGE images using conventional reconstruction and DLR-based methods is inconsistent. Generally, an STRM ≥ 3SD is the optimal reference threshold for clinical use. Quantifying the SD thresholds depends predominantly on the SI and SD of the ROIs drawn in the distal normal myocardium; however, the image quality of the remote normal myocardium may affect the visual sketching of the area to avoid the delayed lesion intensification on LGEDL images [31]. For example, using a lower SD threshold of the distal myocardium leads to a significantly lower threshold for encompassing the extent of delayed enhancement, resulting in underestimation [13]. The SD values, including SDMyo, SDMDEA, and SDBG of the LGEDL images, showed similar patterns and were smaller than those of the LGEO images, consistent with a previous DLR liver study [25]. Higher SNR and CNR values on LGEDL images than on LGEO images corresponded to improved inter- and intra-reader consistency of Parea measurements, indicating a more precise outline of the endocardium, epicardium, and foci boundary in the LGDDL images because of the lower noise levels and fewer motion artifacts, especially in S1 and S16. DL plays a pivotal role in the field of medical image segmentation [17–21]. Currently, manual delineation is subject to certain variabilities. In the future, integrating artificial intelligence-based automatic segmentation optimization may reduce the inconsistencies associated with manual delineation [22, 25–28]. The incremental change in Parea values was inconsistent between segments; for example, S12, a middle segment of the lateral wall, exhibited a higher Parea on LGEDL images than on LGEO images, possibly due to less interference from artifacts and clearer edges of the lesion. Regarding the SD methods, the 4SD and 3SD threshold approaches in this study resulted in the highest inter- and intra-reader consistency for Parea−DL and the highest intra-reader consistency for Parea−O. Therefore, threshold selection for image reconstruction based on conventional and DL-based approaches should be considered cautiously. Consistent with previous findings [12], the Parea−DL did not statistically differ from the Parea−O values when the FWHM method was used, as the technique only results in noise reduction without altering information fidelity on LGEDL images. It yields highly reproducible and consistent enhanced areas regardless of the underlying etiologies for assessing the severity and extent of MI and other myocardial diseases [13, 16, 26, 32, 33].
This was the first study to evaluate and directly compare LGEDL and LGEO images of delayed intensification foci in patients with UMI. The diagnostic performance of the Parea−DL was higher than that of the Parea−O for the threshold approaches, especially for the Parea−DL based on the 5SD threshold, which exhibited the best AUC (0.891). For LGEO images, the Parea−O based on the 3SD threshold exhibited the optimal AUC of 0.840, consistent with data from previous studies recommending using an STRM ≥ 3SD for infarct size. This study recruited patients with UMI without clinically significant cardiogenic chest pain and with a relatively small range of reinforcing foci; these results confirm that the 3SD threshold is sufficient for conventional LGE images. In contrast, a threshold ≥ 4SD should be used for DLR LGE images to optimize the intra- and inter-reader agreement and diagnostic efficacy. The diagnosis of the extent of infarction in UMI-related cases using the 4SD threshold was possibly a more reliable parameter for LGEO and LGEDL images despite the better diagnostic efficacy of the 5SD threshold for LGEDL imaging. Furthermore, the detection rate of UMI was 67% (63/91); this rate was similar for LGEO and LGEDL images despite the better image quality and more reliable assessment of pathological features on LGEDL imaging.
This study has some limitations. First, all participants were recruited using a single-center design, and only those who underwent an MR examination were included for analysis, limiting the generalizability of our results. Despite LGE images with high diagnostic accuracy of MI detection, the final diagnosis relies on experienced radiologists due to the lack of pathological validation for delayed enhancement areas on LGE images. Therefore, to enhance the robustness of result generalization, multicenter and large data, including comparison of Parea−DL and Parea−O using various SD and FWHM methods and validation of the accuracy and reliability for UMI diagnosis should be considered for future LGEO or LGEDL.
Conclusions
The selection of SD thresholds for LGEDL (≥ 4SD) and LGEO (≥ 3SD) images was recommended for future research, as the difference between Parea−DL and Parea−O affected diagnostic efficacy and clinical decision-making in patients with UMI. Moreover, Parea−DL and Parea−O were similar when the FWHM method was used, implying LGEDL images retained informational integrity. Despite the same UMI detection rates between LGEO and LGEDL images, the LGEDL images showed superior image quality and reliable features for diagnosis with more confidence. Therefore, STRM selection and diagnostic outcomes should be carefully utilized and interpreted, particularly for DLR-based CMR images.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Acknowledgements
Our thanks are due to the whole team. In addition, thanks are due to Xiaomin Feng, Jing Xie for various useful suggestions and information collection.
Abbreviations
- MI
Myocardial infarction
- UMI
Unrecognized myocardial infarction
- DLR
Deep learning reconstruction
- SNR
Signal-to-noise ratio
- CNR
Contrast-to-noise ratio
- Parea
Percentage of enhanced area
- STRM
Signal threshold versus reference mean
- SD
Standard deviation
- FWHM
Full width at half maximum
- CMR
Cardiac magnetic resonance
- LGEO
Conventionally constructed late gadolinium enhancement
- LGEDL
Deep learning-based reconstruction late gadolinium enhancement
- MRI
Magnetic resonance imaging
- DL
Deep learning
- cTn
Cardiac troponin
- ROI
Region of interest
- SI
Signal intensity
- ICC
Intraclass correlation coefficients
- ROC
Receiver operating characteristic
- AUC
Area under the curve
Author contributions
XL conceptualization, methodology, data curation, software, experiments, formal analysis, writing – original draft,review and editing of this study. WL conceptualization, methodology, data curation, Formal analysis, Writing – original draft, review and editing of this study. YY experiments, data curation, validation, visualization of this study. WY investigation, methodology, resources, software of this study. CL investigation, methodology, software of this study. WG experiments, data curation, validation of this study. GQ resources, software of this study. JJ data curation, formal analysis of this study. LY data curation, formal analysis of this study. YZ conceptualization of this study, methodology, funding acquisition, data curation, Software, project administration, resources, supervision, writing – review and editing of this study. All authors read and approved the final manuscript.
Funding
This study was supported by the National Natural Science Foundation of China (Grant Numbers 82171895) and the Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University (JCRCZN-2022-013).
Data availability
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
This study conformed with the tenets of the Declaration of Helsinki and was approved by the institutional review board of Renmin Hospital of Wuhan University Clinical Research Ethics Committee (Approval No. 2022 K-K083). All patients provided written informed consent for study inclusion before magnetic resonance scanning.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
The original version of this article was revised: In the CMR examination and image construction section, the authors mistakenly wrote ’field of view = 34 mm‘ instead of 34 cm x 34 cm.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xuefang Lu and Weiyin Vivian Liu contributed equally to this work.
Change history
7/24/2024
A Correction to this paper has been published: 10.1186/s12880-024-01375-5
References
- 1.Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618–51. 10.1161/CIR.0000000000000617 [DOI] [PubMed] [Google Scholar]
- 2.Weir-McCall JR, Fitzgerald K, Papagiorcopulo CJ, Gandy SJ, Lambert M, Belch JJF, Cavin I, Littleford R, Macfarlane JA, Matthew SZ, Nicholas RS, Struthers AD, Sullivan FM, Waugh SA, White RD, Houston JG. Prevalence of unrecognized myocardial infarction in a low–intermediate risk asymptomatic cohort and its relation to systemic atherosclerosis, Eur. Heart J Cardiovasc Imaging. 2017;18:657–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sugiyama T, Kanaji Y, Hoshino M, Hada M, Misawa T, Nagamine T, Teng Y, Matsuda K, Sayama K, Araki M, Usui E, Murai T, Lee T, Yonetsu T, Sasano T, Kakuta T. Relationship between unrecognized myocardial infarction and underlying coronary plaque characteristics on Optical Coherence Tomography. JACC Cardiovasc Imaging. 2022;15:1830–2. 10.1016/j.jcmg.2022.05.021 [DOI] [PubMed] [Google Scholar]
- 4.Dastidar AG, Baritussio A, Garate ED, Drobni Z, Biglino1 G, Singhal P, Milano EG, Angelini GD, Dorman S, Strange J, Johnson T. Bucciarelli-Ducci, prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries. JACC Cardiovasc Imaging. 2019;12:1973–82. 10.1016/j.jcmg.2018.12.023 [DOI] [PubMed] [Google Scholar]
- 5.Pesapane F, Codari M, Sardanelli F. Artificial intelligence in medical imaging: threat or opportunity? Radiologists again at the forefront of innovation in medicine. Eur Radiol Exp. 2018;2:35. 10.1186/s41747-018-0061-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kim C, Park CH, Kim DY, Cha J, Lee BY, Park CH, Kang EJ, Koo HJ, Kitagawa K, Cha MJ, Krittayaphong R, Choi SI, Viswamitra S, Ko SM, Kim SM, Hwang SH, Trang NN, Lee W, Kim YJ, Lee J, Yang DH. Semi-quantitative scoring of late Gadolinium Enhancement of the left ventricle in patients with ischemic cardiomyopathy: improving Interobserver Reliability and Agreement using Consensus Guidance from the Asian Society of Cardiovascular Imaging-Practical Tutorial (ASCI-PT). Eur Heart J Cardiovasc Imaging. 2022;23:298–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cha MJ, Kim SM, Kim Y, Kim HS, Cho SJ, Sung J, Choe YH. Unrecognized myocardial infarction detected on cardiac magnetic resonance imaging: Association with coronary artery calcium score and cardiovascular risk prediction scores in asymptomatic Asian cohort. PLoS ONE. 2018;13:e0204040. 10.1371/journal.pone.0204040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kodai Sayama M, Hoshino Y, Kanaji T, Sugiyama T, Misawa M, Hada T, Nagamine K, Nogami. Yun Teng, Hiroki Ueno, Kazuki Matsuda, Taishi Yonetsu, Tsunekazu Kakuta. Prognostic implications of non-infarct-related territory unrecognized myocardial infarction in patients with non-ST-segment-elevation acute coronary syndrome. J Cardiol. 2023;82:433–40. 10.1016/j.jjcc.2023.06.007 [DOI] [PubMed] [Google Scholar]
- 9.Théo Pezel T, Unterseeh M, Kinnel T, Hovasse F, Sanguineti. Solenn Toupin3, Stéphane Champagne, Philippe Garot1 and Jérôme Garot. Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease. J Cardiovasc Magn Reson. 2021; 23. [DOI] [PMC free article] [PubMed]
- 10.Hoshino M, Sugiyama T, Kanaji Y, Hada M, Nagamine T, Nogami K, Ueno H, Sayama K, Matsuda K. Taishi Yonetsu, Tetsuo Sasano, Tsunekazu Kakuta. Multimodality coronary imaging to predict non-culprit territory unrecognized myocardial infarction in Non-ST-Elevation acute coronary syndrome. Int J Cardiovasc Imaging. 2023;39:2051–61. 10.1007/s10554-023-02903-0 [DOI] [PubMed] [Google Scholar]
- 11.Demirkiran A, Everaars H, Amier RP, Beijnink C, Bom MJ, Götte MJW, van Loon RB, Selder JL, van Rossum AC, Nijveldt R. Cardiovascular magnetic resonance techniques for tissue characterization after acute myocardial injury. Eur Heart J Cardiovasc Imaging. 2019;20:723–34. 10.1093/ehjci/jez094 [DOI] [PubMed] [Google Scholar]
- 12.Pradella S, Mazzoni LN, Letteriello M, Tortoli P, Bettarini S, De Amicis C, et al. FLORA software: semi-automatic LGE-CMR analysis tool for cardiac lesions identification and characterization. Radiol Med. 2022;127:589–601. 10.1007/s11547-022-01491-8 [DOI] [PubMed] [Google Scholar]
- 13.van der Velde N, Hassing HC, Bakker BJ, Wielopolski PA, Lebel RM, Janich MA, et al. Improvement of late gadolinium enhancement image quality using a deep learning–based reconstruction algorithm and its influence on myocardial scar quantification. Eur Radiol. 2021;31:3846–55. 10.1007/s00330-020-07461-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4:150–6. 10.1016/j.jcmg.2010.11.015 [DOI] [PubMed] [Google Scholar]
- 15.Zucker EJ, Sandino CM, Kino A, Lai P, Vasanawala SS. Free-breathing accelerated Cardiac MRI using deep learning: validation in children and young adults. Radiology. 2021;300:539–48. 10.1148/radiol.2021202624 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Giuseppe Muscogiuri C, Martini M, Gatti, et al. Feasibility of late gadolinium enhancement (LGE) in ischemic cardiomyopathy using 2D-multisegment LGE combined with artificial intelligence reconstruction deep learning noise reduction algorithm. Int J Cardiol. 2021;343:164–70. 10.1016/j.ijcard.2021.09.012 [DOI] [PubMed] [Google Scholar]
- 17.Shambhu S, Koundal D, Das P, Sharma C. Binary classification of COVID-19 CT images using CNN: COVID diagnosis using CT. Int J E Health Med Commun. 2021;13:1–13. 10.4018/IJEHMC.20220701.oa4 [DOI] [Google Scholar]
- 18.Shambhu S, Koundal D, Das P. Deep learning-based computer assisted detection techniques for malaria parasite using blood smear images. Int J Adv Technol Eng Explor. 2023;10:990–1015. [Google Scholar]
- 19.Shambhu S, Koundal D, Das P. Edge-based segmentation for accurate detection of malaria parasites in microscopic blood smear images: a novel approach using FCM and MPP algorithms, 2023 2nd International Conference on Smart Technologies and Systems for Next Generation Computing (ICSTSN), Villupuram, India, 2023, pp. 1–6.
- 20.Shambhu S, Koundal D. Recent trends in image processing using granular computing. Lecture Notes Electr Eng. 2020;668.
- 21.Shambhu S, Koundal D, Das P, Hoang VT, Tran-Trung K, Turabieh H. Computational methods for automated analysis of malaria parasite using blood smear images: recent advances. Comput Intell Neurosci. 2022; 3626726. [DOI] [PMC free article] [PubMed]
- 22.Barbier CE, Themudo R, Bjerner T, Johansson L, Lind L, Ahlström H. Long-term prognosis of unrecognized myocardial infarction detected with cardiovascular magnetic resonance in an elderly population. J Cardiovasc Magn Reson. 2016;18:43–9. 10.1186/s12968-016-0264-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cheong BY, Duran C, Preventza OA, Muthupillai R, Muthupillai. Comparison of low-dose higher-relaxivity and standard-dose lower-relaxivity contrast media for delayed-enhancement MRI: a blinded randomized crossover study. Am J Roentgenol. 2015;205:533–9. 10.2214/AJR.14.13749 [DOI] [PubMed] [Google Scholar]
- 24.Andrew S, Flett J, Hasleton C, Cook, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance, JACC. Cardiovasc Imaging. 2011;4:150–6. [DOI] [PubMed] [Google Scholar]
- 25.Chen Q, Fang S, Yuchen Y, Li R, Deng R, Chen Y, Ma D. Huimin Lin, Fuhua Yan. Clinical feasibility of deep learning reconstruction in liver diffusion-weighted imaging: improvement of image quality and impact on apparent diffusion coefficient value. Eur J Radiol. 2023. [DOI] [PubMed]
- 26.Ganesan AN, Gunton J, Nucifora G, McGavigan AD, Selvanayagam JB. Impact of late gadolinium enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: a systematic review and meta-analysis. Int J Cardiol. 2018;254:230–7. 10.1016/j.ijcard.2017.10.094 [DOI] [PubMed] [Google Scholar]
- 27.Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, Arzanauskaite M, Lota A, Tayal U, Vassiliou VS, Gregson J, Alpendurada F, Frenneaux MP, Cook SA, Cleland JGF, Pennell DJ, Prasad SK. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc Imaging. 2019;12:1645–55. 10.1016/j.jcmg.2018.07.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, Yang H. Prognostic value of LGE CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9:1392–402. 10.1016/j.jcmg.2016.02.031 [DOI] [PubMed] [Google Scholar]
- 29.Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Maehara A, Eitel I, Granger CB, Jenkins PL, Nichols M, Ben-Yehuda O. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67:1674–83. 10.1016/j.jacc.2016.01.069 [DOI] [PubMed] [Google Scholar]
- 30.Taylor AM. The role of artificial intelligence in paediatric cardiovascular magnetic resonance imaging. Pediatr Radiol. 2021;22:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bustin A, Janich MA, Brau AC, Odille F, Wolff SD, Shubayev O, Stanley D, Menini A. Joint denoising and motion correction: initial application in single-shot cardiac MRI. J Cardiovasc Magn Reson. 2015;17:Q29. 10.1186/1532-429X-17-S1-Q29 [DOI] [Google Scholar]
- 32.Mikami Y, Kolman L, Joncas SX, Stirrat J, Scholl D, Rajchl M, Lydell CP, Weeks SG, Howarth AG, White JA. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2014;16:85–94. 10.1186/s12968-014-0085-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Antiochos P, Ge Y, Steel K, Bingham S, Abdullah S, Mikolich JR, Arai AE, Bandettini WP, Patel AR, Farzaneh-Far A, Heitner JF, Shenoy C, Leung SW, Gonzalez JA, Shah DJ, Raman SV, Ferrari VA, Schulz-Menger J, Stuber M, Simonetti OP, Kwong RY. SPINS study investigators, imaging of clinically unrecognized myocardial fibrosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 2020;76:945–57. 10.1016/j.jacc.2020.06.063 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.




